ACMG Foundation Corporate Partner Insights Session - Natera: Precision Medicine across Oncology, Renal Genetics and Reproductive Health
19 Mar 2025
Venue:
Los Angeles Convention Centre
Meeting Room:
408 A
The session will provide insights on how genomic testing in oncology, renal genetics and reproductive health can enable personalized care and improve outcomes.
This session will explore:
- How data from molecular residual disease testing can enhance awareness of hereditary cancer testing
- The interaction between the genetic causes of kidney disease and targeted therapies
- How expansion of prenatal screening improves outcomes through early diagnosis and perinatal treatment options
Speakers
Sheetal Parmar, MS CGC, Natera
John Williams III, MD, Cedars-Sinai Medical Center and the David Geffen School of Medicine at UCLA
Katya Brossart, MS, CGC, Natera Organ Health
Eileen Hoffman, MS, CGC, Natera
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
)
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}